Amazon Peptide Sale Investigation
Migliaccio & Rathod LLP is investigating Amazon’s practice of selling non-FDA approved peptides. Amazon Peptide Investigation According to the Associated Press, Amazon […]
Tag: fda
Investigation of Acne Treatment Products Containing Benzene
Migliaccio & Rathod LLP is currently investigating several skincare and cosmetics brands, including Clinique and Clearasil, due to reports of high levels […]
WanaBana, Schnucks and Weis Puree Products Cause Lead Poisoning in Children
Migliaccio & Rathod is currently investigating WanaBana, Schnucks and Weis products for reportedly causing acute lead poisoning in children. The products include […]
Ineffective Store Brand Cold Medicine Investigation
Migliaccio & Rathod is investigating several national and regional retailers for selling oral cold medicine and decongestants containing the drug phenylephrine, which […]
Quinapril HCI/Hydrochlorothiazide Recall Investigation
UPDATE: This investigation is now closed. For further assistance, we recommend reaching out to an attorney who specializes in individual based personal […]
CLOSED: Investigation of Antiperspirant Body Sprays Contaminated with Benzene
UPDATE: We are no longer investigating this potential suit. Please contact individual counsel should you believe you may have potential claims for […]
Injectafer Dangerous Side Effects Investigation
Migliaccio & Rathod LLP is currently investigating the pharmaceutical manufacturers of the widely used iron-deficiency anemia drug, Injectafer. Injectafer has been […]
Metformin Carcinogenic Contaminants Investigation
Migliaccio & Rathod LLP is currently investigating manufacturers of the widely used diabetes drug metformin, known by the common brand names […]
Ranitidine Carcinogenic Contaminants Investigation
Migliaccio & Rathod LLP is currently investigating manufacturers of the prescription and over-the-counter heartburn medication ranitidine, known by the brand name […]
Valsartan Carcinogenic Contaminants Investigation
Migliaccio & Rathod LLP has filed a class action lawsuit against certain manufacturers of Valsartan, an angiotensin II receptor blocker used […]